Jill Jobbins Advisory, LLC leverages 15+ years of experience in managing global pharmaceutical product portfolios for value. Jill is a pace setter in business management focused on creating strategy and unique operating models that deliver maximum financial outcomes. Jill thrives on solving complex problems using innovative approaches. She is known for aligning cross-functional executives behind a common vision.
Core Competencies
- Portfolio / Lifecycle Management
- Strategy and Operating Model Development
- Brand Value Generation
Portfolio/Lifecycle Management
Led the strategic direction of a large and therapeutically diverse established product portfolio. Designed and enabled a comprehensive approach in deriving optimal value from a $2.2B portfolio.
- Developed portfolio strategy and execution plans for over 70 Brands commercialized in over 100 markets to maximize portfolio value; delivered strong and stable financial performance over multiple years.
- Managed Strategic Product Leads for several marketed brands to maximize value through product loss of exclusivity.
- Directed lifecycle management by growing the depth and breadth of commercial relationships, optimizing total supply chain, enhancing productivity, enabling cost reduction and managing diverse functional teams.
Strategy and Operating Model Development
Experienced in driving strategy to expand the commercial reach of products utilizing a lean business model designed to support business and extract lucrative opportunities in geographically diverse markets. Adept in developing business strategies.
- Established a Center of Excellence and globally leveraged best practices related to compliance, business models and contract structure.
- Expanded the commercial reach of pharmaceutical assets (early to late stage) into Asia, Latin America and Middle East.
- Installed and managed multiple contractural engagements with full-service providers in remote geographies to ensure patient access to pharmaceutical products.
- Developed and implemented strategic business plans to form and grow several new ventures: Sterile Fill/Finish, Specialty Laminate Intermediates, Formulation Services.
Brand Value Generation
Consistently maximized the value of branded pharmaceutical products.
- Championed a strategic road-map by brand and by market ensuring capture and execution of high-potential opportunities resulting in over $100 million of incremental value.
- Identified and developed a hepatitis C opportunity of $70M peak revenue potential for Asian markets.
- Successfully launched products in remote markets using direct importation processes.
Jill Jobbins Advisory 